Patent applications and USPTO patent grants for Vasogen Ireland Limited.The latest application filed is for "pharmaceutically acceptable phosphate-glycerol carrying bodies".
Patent | Date |
---|---|
Apoptosis-mimicking synthetic entities and use thereof in medical treatment Grant 7,597,906 - Bolton , et al. October 6, 2 | 2009-10-06 |
Pharmaceutically Acceptable Phosphate-glycerol Carrying Bodies App 20080171082 - BOLTON; Anthony Ernest ;   et al. | 2008-07-17 |
Pharmaceutically Acceptable Phosphate-glycerol Carrying Bodies App 20080166400 - BOLTON; Anthony Ernest ;   et al. | 2008-07-10 |
Pharmaceutically Acceptable Phosphate-glycerol Carrying Bodies App 20080160074 - BOLTON; Anthony Ernest ;   et al. | 2008-07-03 |
Acute Inflammatory Condition Treatment App 20080138432 - Mandel; Arkady ;   et al. | 2008-06-12 |
Apoptotic Entities For Use In Treatment Of Neurodegenerative And Other Neurological Disorders App 20080131416 - Bolton; Anthony E. ;   et al. | 2008-06-05 |
Apoptosis-mimicking Synthetic Entities And Use Thereof In Medical Treatment App 20080124386 - BOLTON; Anthony E. ;   et al. | 2008-05-29 |
Multi-outlet medical dispensing device Grant 7,361,164 - Simpson , et al. April 22, 2 | 2008-04-22 |
Pharmaceutically Acceptable Phosphate-glycerol Carrying Bodies App 20080075764 - BOLTON; Anthony Ernest ;   et al. | 2008-03-27 |
Apoptotic Entities For Use In Treatment Of Endothelium Dysfunction Disorders App 20080063631 - Bolton; Anthony E. ;   et al. | 2008-03-13 |
Apoptotic Entities For Use In Treatment Of Endothelium Dysfunction Disorders App 20070298020 - Bolton; Anthony E. ;   et al. | 2007-12-27 |
Device and method for controlled expression of gases from medical fluids delivery systems App 20070276323 - Matsuura; David G. ;   et al. | 2007-11-29 |
Acute Inflammatory Condition Treatment App 20070238708 - Mandel; Arkady ;   et al. | 2007-10-11 |
Apoptotic entities for use in treatment of endothelium dysfunction disorders Grant 7,279,156 - Bolton , et al. October 9, 2 | 2007-10-09 |
Material dispenser with a solenoid lock App 20070225653 - Lim; Bernard C.B. ;   et al. | 2007-09-27 |
Apoptosis-mimicking Synthetic Entities And Use Thereof In Medical Treatment App 20070224256 - BOLTON; Anthony E. ;   et al. | 2007-09-27 |
Apparatus and process for conditioning mammalian blood Grant 7,273,586 - Mongomery , et al. September 25, 2 | 2007-09-25 |
Medical treatment control system App 20070191787 - Lim; Bernard C.B. ;   et al. | 2007-08-16 |
Treatment of endothelin-related disorders Grant 7,255,880 - Bolton , et al. August 14, 2 | 2007-08-14 |
Material dispenser with a control valve App 20070179453 - Lim; Bernard C.B. ;   et al. | 2007-08-02 |
Apparatus and process for conditioning mammalian blood Grant 7,250,137 - Mongomery , et al. July 31, 2 | 2007-07-31 |
Valve assembly App 20070120083 - Simpson; Philip J. ;   et al. | 2007-05-31 |
Method for treating mammals with modified mammalian blood Grant 7,223,391 - Bolton May 29, 2 | 2007-05-29 |
Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders App 20070087010 - Bolton; Anthony E. ;   et al. | 2007-04-19 |
Treatment of inflammation and vascular abnormalities of the eye App 20070071805 - Mandel; Arkady ;   et al. | 2007-03-29 |
Controlled flow adapter with piercing end for medical fluid containers App 20070016161 - Costa; Mark Paul ;   et al. | 2007-01-18 |
Treatment of congestive heart failure Grant 7,153,649 - Smith , et al. December 26, 2 | 2006-12-26 |
Permission-based material dispenser App 20060270997 - Lim; Bernard C.B. ;   et al. | 2006-11-30 |
Sample management unit App 20060270961 - Costa; Mark P. ;   et al. | 2006-11-30 |
Verification method and system for medical treatment App 20060264778 - Lim; Bernard C.B. ;   et al. | 2006-11-23 |
Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders Grant 7,132,285 - Bolton , et al. November 7, 2 | 2006-11-07 |
Apparatus and process for conditioning mammalian blood Grant 7,128,873 - Mongomery , et al. October 31, 2 | 2006-10-31 |
Combined therapies for atherosclerosis treatment Grant 7,125,897 - Elsley October 24, 2 | 2006-10-24 |
Compositions containing apoptotic entities Grant 7,122,208 - Bolton , et al. October 17, 2 | 2006-10-17 |
Multiport syringe App 20060224125 - Simpson; Philip J. ;   et al. | 2006-10-05 |
Controlled flow adapter for medical fluid containers App 20060211996 - Trinchera; James A. ;   et al. | 2006-09-21 |
Controlled flow apparatus for medical accessories App 20060149211 - Simpson; Philip J. ;   et al. | 2006-07-06 |
Pre-conditioning cells against death App 20060127383 - Hamet; Pavel ;   et al. | 2006-06-15 |
Device and method for controlled expression of gases from medical fluids delivery systems App 20060111667 - Matsuura; David G. ;   et al. | 2006-05-25 |
Accelerating recovery from trauma App 20060105031 - Bolton; Anthony E. ;   et al. | 2006-05-18 |
Apparatus and process for conditioning mammalian blood App 20060084905 - Montgomery; Sonya ;   et al. | 2006-04-20 |
Method for treating mammals with modified mammalian blood Grant 6,986,888 - Bolton January 17, 2 | 2006-01-17 |
Multi-outlet medical dispensing device App 20050245872 - Simpson, Philip J. ;   et al. | 2005-11-03 |
Method for treating mammals with modified mammalian blood App 20050238623 - Bolton, Anthony E. | 2005-10-27 |
Apoptosis-mimicking synthetic entities and use thereof in medical treatment Grant 6,953,591 - Bolton , et al. October 11, 2 | 2005-10-11 |
Syringe adaptor Grant D508,995 - Mitchell , et al. August 30, 2 | 2005-08-30 |
Medical material handling systems App 20050154368 - Lim, Bernard C.B. ;   et al. | 2005-07-14 |
Medical treatment management systems App 20050139651 - Lim, Bernard C.B. ;   et al. | 2005-06-30 |
Apoptosis-mimicking synthetic entities and use thereof in medical treatment App 20050123598 - Bolton, Anthony E. ;   et al. | 2005-06-09 |
Apparatus and process for conditioning organic fluid Grant 6,802,892 - Newman , et al. October 12, 2 | 2004-10-12 |
Apparatus and process for conditioning mammalian blood App 20040199097 - Mongomery, Sonya ;   et al. | 2004-10-07 |
Method for treating autoimmune and alloimmune diseases Grant 6,800,300 - Miller , et al. October 5, 2 | 2004-10-05 |
Apparatus and process for conditioning mammalian blood Grant 6,736,788 - Mongomery , et al. May 18, 2 | 2004-05-18 |
Chronic lymphocytic leukemia treatment Grant 6,733,748 - Spaner May 11, 2 | 2004-05-11 |
Apparatus and process for conditioning organic fluid Grant 6,719,715 - Newman , et al. April 13, 2 | 2004-04-13 |
Endothelial lining effects and treatment of vasospastic disorders Grant 6,696,092 - Bolton February 24, 2 | 2004-02-24 |
Method of treating atherosclerosis Grant 6,669,965 - Bolton December 30, 2 | 2003-12-30 |
Treatment of congestive heart failure Grant 6,572,895 - Smith , et al. June 3, 2 | 2003-06-03 |
Disposable biological fluid container Grant D463,864 - Treadwell , et al. October 1, 2 | 2002-10-01 |
Inhibition of graft versus host disease Grant 6,258,357 - Spaner July 10, 2 | 2001-07-10 |
Treatment of autoimmune diseases Grant 6,204,058 - Bolton March 20, 2 | 2001-03-20 |
Treatment of autoimmune diseases Grant 5,980,954 - Bolton November 9, 1 | 1999-11-09 |
SEC | 0001342482 | VASOGEN IRELAND LTD |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.